DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Darglitazone
Darglitazone
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Diabetes-Related Biomarkers and Methods of Use Thereof
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
2013 Proceedings Annual Conference AAZV 1 GEORGIA WILDLIFE HEALTH PROGRAM and the GEORGIA SEA TURTLE CENTER Terry M. Norton
Peroxisome Proliferator-Activated Receptors As Superior Targets to Treat Diabetic Disease, Design Strategies - Review Article
(12) Patent Application Publication (10) Pub. No.: US 2008/0058292 A1 Tawakol (43) Pub
Stembook 2018.Pdf
Role of Glitazars in Atherogenic Dyslipidemia and Diabetes: Two Birds with One Stone?
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
Peroxisome Proliferator-Activated Receptors
Diabetes Europe 2018: in Vivo Assessment of Thiazolidinedione Subsidiaries As Euglycemic Specialists- Diana Aleman- National Polytechnic Institute
WO 2015/166472 Al 5 November 2015 (05.11.2015) P O P C T
Quantitative Structural Assessment of Graded Receptor Agonism
In Vitro Approaches to Assess Mitochondrial Toxicity And
WO 2016/066668 Al 6 May 2016 (06.05.2016) P O P C T
The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
Peroxisome Proliferator-Activated Receptor Gamma Ligand Eluting Medical Device
A Phase II Study of Pioglitazone for Patients with Cancer of the Pancreas
Top View
Insulin Glargine Combined with Oral Agent in T2DM
Customs Tariff - Schedule Xxi - 1
Supplementary Materials: Building and Testing Pparγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
( 12 ) United States Patent
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Review Article and Clinical Experience
Adipose Tissue Expression of the Lipid Droplet–Associating Proteins
Review Article
Quantitative Structural Assessment of Graded Receptor Agonism
Tepzz 59Z6¥4B T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability Nicholas D
Reply to “A “Futile Cycle” Induced by Thiazolidinediones in Human
Wo 2010/045656 A2
Download Product Insert (PDF)
Identification and Characterization of Antidiabetic And
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Will Lecture Sot2008a
The Journey of Thiazolidinediones As Modulators of Ppars for the Management of Diabetes: a Critical Review
WO 2017/198177 Al 23 November 2017 (23.11.2017) W !P O PCT